Breaking News
Get 40% Off 0
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now
Close

Artgen Biotekh PAO (ABIO)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
113.00 +1.48    +1.33%
03/05 - Closed. Currency in RUB ( Disclaimer )
  • Volume: 1,476,370
  • Bid/Ask: 113.00 / 113.12
  • Day's Range: 112.30 - 118.00
Type:  Equity
Market:  Russia
ISIN:  RU000A0JNAB6 
S/N:  1-01-08902-A
Artgen 113.00 +1.48 +1.33%

Artgen Biotekh PAO Company Profile

 
Get an in-depth profile of Artgen Biotekh PAO, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryHealthcare Providers & Services
SectorHealthcare
Employees

-

Equity Type

ORD

Artgen Biotech PJSC, a biotech company, engages in the development of healthcare products in Russia. It develops Betuvax-CoV-2, a vaccine for SARS-COV-2; Tetraflubet, a Flu vaccination; Combi 5V, a Flu + COVID-19 booster vaccine; Betusphere for Immunomodulator; RBT-402, a HPV vaccine; and RBT-501, a vaccine for natural allergy. The company also offers Histograft, a Gene-activated material used as an osteoplastic material, as well as biobanking, genetic research, and regenerative medicine services. In addition, it develops various medical products, such as Xeno-Bone for bone grafting in open operations; Inject-Bone for minimally invasive bone grafting; Inject-Soft use for damage to the skin and mucous membranes; 3D-Bone use for replacement od volumetric bone defects; Cover Bone for guided bone regeneration; and Supl-Bone for bone grafting. The company was formerly known as Public Joint-Stock Company "Human Stem Cells Institute". The company was founded in 2003 and is based in Moscow, Russia.

Contact Information

Address st. Gubkina d.3, building 2 PO Box 373
Moscow, 119333
Russia
Phone 7 495 646 8076
Fax -
Web artgen.ru

Top Executives

Name Age Since Title
Potapov Ivan Viktorovich - - Member of Scientific Advisory Board
Boguslavsky Dmitry Edgardovich 42 - Independent Director
Konstantin Mauer - - Independent Director
Kiselev Sergey Lvovich 65 - Member of Scientific Advisory Board & Independent Director
Svetlana Samoylova - 2017 Member of Audit Commission
Vyacheslav Vyacheslavovich Shulenin - - Independent Director
Deev Roman Vadimovich - - Chief Scientific Officer, Director & Member of Scientific Advisory Board
Oksana Peterson - - Deputy Chief Accountant & Member of Audit Commission
Zorin Vadim Leonidovich - 2016 Head of Regenerative Medicine Department & Member of Scientific Advisory Board
Isaev Andrei Aleksandrovich 53 2020 Founder & Director
Prikhodko Alexander Viktorovich 65 2012 General Director & Director
Artur Aleksandrovich Isaev 54 - Chairman & Member of Scientific Advisory Board
Blokhina Svetlana Viktorovna - - Head of Corporate Department & Chairman of Audit Commission
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

ABIO Comments

Write your thoughts about Artgen Biotekh PAO
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email